Here's a Bull Spread strategy on Sun Pharma by Nandish Shah of HDFC Sec

The stock price has witnessed running correction of 10 per cent from the recent high

stock, market, shares, investment, investors, trading, sensex, growth, technology
Nandish Shah Mumbai
1 min read Last Updated : Feb 12 2021 | 8:19 AM IST
Bull spread Strategy on Sun Pharma 

Buy Sun Pharma Feb 650 Call at Rs 20 & simultaneously sell Feb 680 Call at Rs 10 

Lot Size: 1,400 

Cost of the strategy: Rs 10 (Rs 14,000 per strategy) 

Maximum profit: Rs 28,000 If Sun Pharma closes at or above 680 on 25 Feb expiry. 

Breakeven Point: Rs 660 

Also Read


Rationale: 

-- Long build-up was seen in Sun Pharma Futures’ where we have seen 7 per cent rise in the Open Interest with price rising by 2 per cent. 

-- The stock price has broken out on the daily chart, where it closed at highest level since September 2018, with higher volumes 

-- Oscillators like RSI and MFI are showing strength in the stock 

-- Primary trend of the stock is positive where it is trading above its 100- and 200-day EMA.  

-- The stock price has witnessed running correction of 10 per cent from the recent high 
Disclaimer: Nandish Shah is Technical Research Analyst at HDFC Securities. He doesn't hold any position in the stock. Views are personal.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :MarketsMarket technicalsSun PharmaHDFC Securitiesstocks technical analysistechnical analysis

Next Story